TRAWS PHARMA INC (TRAW) Stock News

NASDAQ:TRAW - Nasdaq - US68232V8845 - Common Stock - Currency: USD

1.46 -0.08 (-5.19%)

After market: 1.4501 -0.01 (-0.68%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

TRAW Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Traws Pharma, Inc.

Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions

a month ago - By: Traws Pharma, Inc.

Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions

2 months ago - By: Benzinga - Mentions: BIAF PRZO ADBE CGBS ...

Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

2 months ago - By: Benzinga - Mentions: INTS RSLS IMAB CLNN ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

2 months ago - By: Traws Pharma, Inc.

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib

2 months ago - By: Traws Pharma, Inc.

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib

2 months ago - By: Traws Pharma, Inc.

Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness

3 months ago - By: Traws Pharma, Inc.

Traws Pharma Reports First Quarter 2025 Results and Business Highlights

3 months ago - By: Traws Pharma, Inc.

Traws Pharma Reports First Quarter 2025 Results and Business Highlights

4 months ago - By: Traws Pharma, Inc.

Traws Pharma Reports Full Year 2024 Results and Business Highlights

4 months ago - By: Traws Pharma, Inc.

Traws Pharma Reports Full Year 2024 Results and Business Highlights

4 months ago - By: Traws Pharma, Inc.

Traws Pharma Announces Management Updates

4 months ago - By: Traws Pharma, Inc. - Mentions: IOVA IKNA

Traws Pharma Announces Management Updates

4 months ago - By: Traws Pharma, Inc.

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET

4 months ago - By: Traws Pharma, Inc.

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET

4 months ago - By: Traws Pharma, Inc.

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

4 months ago - By: Traws Pharma, Inc.

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

4 months ago - By: Traws Pharma, Inc.

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

4 months ago - By: Traws Pharma, Inc.

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

4 months ago - By: Traws Pharma, Inc.

Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR

4 months ago - By: Traws Pharma, Inc.

Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR

5 months ago - By: Traws Pharma, Inc.

Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil

5 months ago - By: Traws Pharma, Inc.

Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil

5 months ago - By: Traws Pharma, Inc.

Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

5 months ago - By: Traws Pharma, Inc.

Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

6 months ago - By: Traws Pharma, Inc.

News Image

Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu

7 months ago - By: Expert Systems, Inc.

Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program